“Patients with pulmonary edema generally describe breathlessness. Sometimes they feel like they are suffocating or breathing ...

Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

In ‘Made in SG’ Melanie Oliveiro profiles the locally founded Pulmonary Hypertension Support Group (PHSG), a patient support ...

Pulmonary fibrosis is a condition that causes lung scarring and stiffness. This makes it difficult to breathe. It can prevent your body from getting enough oxygen and may eventually lead to ...

The pulmonary valve is located between the right ventricle and the pulmonary artery. The valve acts as a doorway that lets blood into and out of the heart. Pulmonary valve stenosis is when the ...

The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...

Saddle pulmonary embolism describes a large blood clot that sits atop or “saddles” the main pulmonary artery where it divides and branches into the left and right lungs. It can cause breathing ...